NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns

RecruitingN/A

Sponsor: Association Clinique Thérapeutique Infantile du val de Marne

Conditions: Pneumococcal Infections, Pneumococcal Conjugate Vaccine, Antibiotic Treatment, Mortality

Countries: France

After 7 then 13 valent pneumococcal conjugate vaccine (PCV) implementation in France in children, we will evaluate the impact of this vaccination on invasive pneumococcal disease (IPD). We will describe the clinical characteristics of IPD, pneumococcus serotyping, underlying conditions and vaccination status.

Eligibility overview

Sex: ALL

Age: 1 Day to 18 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Isolate of Streptococcus pneumoniae from at least one blood culture, or pleural fluid, or joint fluid, or cerebrospinal fluid or other normally sterile body site, or if there is a positive blood polymerase chain reaction (PCR).

Exclusion Criteria:

* Pneumococcal strain not transmetted to National Reference Center for Pneumococci or to Regional Pneumococci Observatory

Locations (1)

Créteil, France